1. Hirose A., Kato T., Ohno Y., Shimizu H., Tanaka H., Nakamura M., Katsube J. (1990): Pharmacological Actions of SM-9018, a New Neuroleptic Drug with Both Potent 5-Hydroxytryptamine2 and Dopamine2 Antagonistic Actions. Japan. J. Pharmacol., 53, 321–329.
2. Fujimoto K., Mizuno Y., Kanamaru H., Nakatsuka I. (1997): Identification of metabolites of perospirone. Clinical Report, 31(2), 581–657.
3. Mizuno Y., Kanamaru H., Nakatsuka I. (1997): Metabolic Profile in Serum after Single Oral Administration of14C-SM-9018 to Rats. Clinical Report, 31(2), 689–705.
4. Mizuno Y., Kanamaru H., Nakatsuka I. (1997): Disposition of SM-9018 after Single Oral Administration to Rat and Protein Binding to Serum of Human and Animals. Clinical Report, 31(2), 543–568.
5. Mizuno Y., Kanamaru H., Nakatsuka I., Miyoshi K., Hanawa S., Hayashi K., Esumi Y. (1997): Disposition of [carbonyl-14C]SM-9018 in Cynomolgus monkeys. Clinical Report, 31(2), 799–809.